Cargando…

Filoviral Immune Evasion Mechanisms

The Filoviridae family of viruses, which includes the genera Ebolavirus (EBOV) and Marburgvirus (MARV), causes severe and often times lethal hemorrhagic fever in humans. Filoviral infections are associated with ineffective innate antiviral responses as a result of virally encoded immune antagonists,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanan, Parameshwaran, Shabman, Reed S., Brown, Craig S., Amarasinghe, Gaya K., Basler, Christopher F., Leung, Daisy W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187693/
https://www.ncbi.nlm.nih.gov/pubmed/21994800
http://dx.doi.org/10.3390/v3091634
_version_ 1782213331897024512
author Ramanan, Parameshwaran
Shabman, Reed S.
Brown, Craig S.
Amarasinghe, Gaya K.
Basler, Christopher F.
Leung, Daisy W.
author_facet Ramanan, Parameshwaran
Shabman, Reed S.
Brown, Craig S.
Amarasinghe, Gaya K.
Basler, Christopher F.
Leung, Daisy W.
author_sort Ramanan, Parameshwaran
collection PubMed
description The Filoviridae family of viruses, which includes the genera Ebolavirus (EBOV) and Marburgvirus (MARV), causes severe and often times lethal hemorrhagic fever in humans. Filoviral infections are associated with ineffective innate antiviral responses as a result of virally encoded immune antagonists, which render the host incapable of mounting effective innate or adaptive immune responses. The Type I interferon (IFN) response is critical for establishing an antiviral state in the host cell and subsequent activation of the adaptive immune responses. Several filoviral encoded components target Type I IFN responses, and this innate immune suppression is important for viral replication and pathogenesis. For example, EBOV VP35 inhibits the phosphorylation of IRF-3/7 by the TBK-1/IKKε kinases in addition to sequestering viral RNA from detection by RIG-I like receptors. MARV VP40 inhibits STAT1/2 phosphorylation by inhibiting the JAK family kinases. EBOV VP24 inhibits nuclear translocation of activated STAT1 by karyopherin-α. The examples also represent distinct mechanisms utilized by filoviral proteins in order to counter immune responses, which results in limited IFN-α/β production and downstream signaling.
format Online
Article
Text
id pubmed-3187693
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-31876932011-10-12 Filoviral Immune Evasion Mechanisms Ramanan, Parameshwaran Shabman, Reed S. Brown, Craig S. Amarasinghe, Gaya K. Basler, Christopher F. Leung, Daisy W. Viruses Review The Filoviridae family of viruses, which includes the genera Ebolavirus (EBOV) and Marburgvirus (MARV), causes severe and often times lethal hemorrhagic fever in humans. Filoviral infections are associated with ineffective innate antiviral responses as a result of virally encoded immune antagonists, which render the host incapable of mounting effective innate or adaptive immune responses. The Type I interferon (IFN) response is critical for establishing an antiviral state in the host cell and subsequent activation of the adaptive immune responses. Several filoviral encoded components target Type I IFN responses, and this innate immune suppression is important for viral replication and pathogenesis. For example, EBOV VP35 inhibits the phosphorylation of IRF-3/7 by the TBK-1/IKKε kinases in addition to sequestering viral RNA from detection by RIG-I like receptors. MARV VP40 inhibits STAT1/2 phosphorylation by inhibiting the JAK family kinases. EBOV VP24 inhibits nuclear translocation of activated STAT1 by karyopherin-α. The examples also represent distinct mechanisms utilized by filoviral proteins in order to counter immune responses, which results in limited IFN-α/β production and downstream signaling. Molecular Diversity Preservation International (MDPI) 2011-09-07 /pmc/articles/PMC3187693/ /pubmed/21994800 http://dx.doi.org/10.3390/v3091634 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Ramanan, Parameshwaran
Shabman, Reed S.
Brown, Craig S.
Amarasinghe, Gaya K.
Basler, Christopher F.
Leung, Daisy W.
Filoviral Immune Evasion Mechanisms
title Filoviral Immune Evasion Mechanisms
title_full Filoviral Immune Evasion Mechanisms
title_fullStr Filoviral Immune Evasion Mechanisms
title_full_unstemmed Filoviral Immune Evasion Mechanisms
title_short Filoviral Immune Evasion Mechanisms
title_sort filoviral immune evasion mechanisms
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187693/
https://www.ncbi.nlm.nih.gov/pubmed/21994800
http://dx.doi.org/10.3390/v3091634
work_keys_str_mv AT ramananparameshwaran filoviralimmuneevasionmechanisms
AT shabmanreeds filoviralimmuneevasionmechanisms
AT browncraigs filoviralimmuneevasionmechanisms
AT amarasinghegayak filoviralimmuneevasionmechanisms
AT baslerchristopherf filoviralimmuneevasionmechanisms
AT leungdaisyw filoviralimmuneevasionmechanisms